zambia herald : Latest News and In-depth Analysis

Opinion

CLPS Incorporation Announces the Launch of Nibot RPA Product, Expanding Automation Services into the Global Market

HONG KONG,Feb. 7,2025-- CLPS Incorporation (the "Company" or "CLPS") (Nasdaq: CLPS),today announced the launch of Nibot,a new generation of Robotic Process Automation (RPA) product

Feb 10, 2025 Opinion

'The convergence between of AI and the Biology' LG Creates "Next-Generation Protein Structure Prediction AI" for Drug Discovery

SEOUL,South Korea,Feb. 7,2025-- On the 5th,LG AI Research signed a joint research agreement at the Global Lounge of LG Science Park in Magok,Gangseo-gu,Seoul,with Prof. Min-Kyung Baek from the school

Feb 10, 2025 Opinion

"SPRING IN HO CHI MINH CITY" - A CELEBRATION OF VIETNAM'S ENTERING NEXT CHAPTER

HO CHI MINH CITY,Vietnam,Feb. 10,2025-- A news report by Nhat Anh Media: As Vietnam enters a new era of growth,"Spring in Ho Chi Minh City" gala emerges,capturing the dynamic spirit of Ho Ch

Feb 10, 2025 Opinion

SANS PRĖCĖDENT - TWO LEGENDS EXPLORE ONE OF THE WORLD'S MOST RESPECTED VARIETALS

ADELAIDE,Australia,Feb. 10,2025-- Introducing Grange La Chapelle 2021,the result of curiosity and exploration that united cultures across two hemispheres. A blend that truly intertwines the rich herit

Feb 10, 2025 Opinion

Actinogen announces new and unique nonproprietary name of 'emestedastat' for Xanamem

Late-stage Alzheimer\'s trial opens 10 new sites in USA,with results due in 2025 and 2026 SYDNEY,Feb. 5,2025-- Actinogen Medical Limited (ASX: ACW) announces that the World Health Organization (WHO)

Feb 7, 2025 Opinion

Serplulimab Approved in the EU for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Serplulimab is the world\'s first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC

Feb 7, 2025 Opinion
1 ... 72 73 74 75 76 77 78 ... 111